The use of large batches of cryopreserved cells for HTS or secondary screening can significantly shorten timelines and lower overall assay costs. ChanTest’s Large-Scale Cryopreservation Service delivers screening-ready batches of cryopreserved cells for screening and profiling studies.

ChanTest’s Cryorpreservation Service includes:

• Clear communication with customer (under terms of a CDA) to detail the scope, methods and materials for the project
• Cell quarantine and Mycoplasma testing.
• Cell expansion and harvesting (either enzymatically or non-enzymatically).
• Cell counting and resuspension at a density and volume specified by Customer.
• Automated cryopreservation to insure optimal cell viability.
• Quality control testing for cell viability, Mycoplasma and functionality.
• Delivery of cells along with a comprehensive report.

Capacity & Capabilities:

• Up to 10 billion adherent cells per batch
• Cells can be automatically dispensed into 96- or 384-well plates and sealed
• Cells can be harvested and processed into membranes for radioligand binding

Advantages:

• Reduced labor and assay costs
• Frees resources for drug discovery efforts
• Reduced assay variability and program delays

We serve many of the world’s leading PharmaBiotech Companies. Let us show you how we can help.

Ordering Information:
To discuss your requirements, timing and pricing please call 216-332-1665 or email inquiries@chantest.com.